It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

Moderate to Severe Overactive Bladder Study

Clinical Trial Protocol ID: 
11052002
Clinical Trial Investigator Name: 
Barbara Soltes, MD

This is a study for men and women with moderate to severe urinary urge incontinence with symptoms for greater than six months.

Treatment is for 12 weeks with a medication that is currently approved for use in this indication and is comparing efficacy between two doses of the medication and placebo.

There are three clinic visits and two telephone contacts.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 18 years old or greater
  • Have symptoms of overactive bladder for more than six months
  • Have a urinary frequency (using restroom) eight or more times per 24 hours
  • Have occasions of incontinence (leaking)

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Contact Name: 
Carol Miller
Contact Phone: 
(312) 563-2611